1-9 of 9
Tadao Akizawa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis

Subject Area:
Nephrology
Tadao Akizawa, Yusuke Yamaguchi, Tetsuro Otsuka, Michael Reusch
Journal: Nephron
Nephron (2020) 144 (8): 372–382.
https://doi.org/10.1159/000508100
Published Online: 24 June 2020
View article titled, A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis
Open the PDF for A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis in another window
Journal Articles

Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease

Subject Area:
Nephrology
Tadao Akizawa, Iain C. Macdougall, Jeffrey S. Berns, Hiroyasu Yamamoto, Megumi Taguchi, Kazuma Iekushi, Thomas Bernhardt
Journal: Nephron
Nephron (2019) 143 (4): 243–254.
https://doi.org/10.1159/000502012
Published Online: 06 August 2019
View article titled, Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease
Open the PDF for Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease in another window
Journal Articles

Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial

Subject Area:
Nephrology
Tadao Akizawa, Masaomi Nangaku, Takuhiro Yamaguchi, Masanobu Arai, Ryosuke Koretomo, Kazuo Maeda, Yuya Miyazawa, Hideki Hirakata
Journal: Nephron
Nephron (2019) 143 (2): 77–85.
https://doi.org/10.1159/000500487
Published Online: 22 May 2019
View article titled, Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial
Open the PDF for Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial in another window
Journal Articles

Increased Mortality Rate after Hospitalization Among Chronic Hemodialysis Patients: A Prospective Cohort Study

Subject Area:
Nephrology
Sayaka Shimizu, Shingo Fukuma, Tatsuyoshi Ikenoue, Tadao Akizawa, Shunichi Fukuhara
Journal: Nephron
Nephron (2018) 140 (3): 194–202.
https://doi.org/10.1159/000492083
Published Online: 28 August 2018
View article titled, Increased Mortality Rate after Hospitalization Among Chronic Hemodialysis Patients: A Prospective Cohort Study
Open the PDF for Increased Mortality Rate after Hospitalization Among Chronic Hemodialysis Patients: A Prospective Cohort Study in another window
Journal Articles

Minor Elevation in C-Reactive Protein Levels Predicts Incidence of Erythropoiesis-Stimulating Agent Hyporesponsiveness among Hemodialysis Patients

Subject Area:
Nephrology
Miho Kimachi, Shingo Fukuma, Shin Yamazaki, Yosuke Yamamoto, Tadao Akizawa, Takashi Akiba, Akira Saito, Shunichi Fukuhara
Journal: Nephron
Nephron (2015) 131 (2): 123–130.
https://doi.org/10.1159/000438870
Published Online: 08 September 2015
View article titled, Minor Elevation in C-Reactive Protein Levels Predicts Incidence of Erythropoiesis-Stimulating Agent Hyporesponsiveness among Hemodialysis Patients
Open the PDF for Minor Elevation in C-Reactive Protein Levels Predicts Incidence of Erythropoiesis-Stimulating Agent Hyporesponsiveness among Hemodialysis Patients in another window
Journal Articles

Nafamostat Mesilate: A Regional Anticoagulant for Hemodialysis in Patients at High Risk for Bleeding

Subject Area:
Nephrology
Tadao Akizawa, Shozo Koshikawa, Kazuo Ota, Mutsuyoshi Kazama, Nobuhide Mimura, Yoshihei Hirasawa
Journal: Nephron
Nephron (1993) 64 (3): 376–381.
https://doi.org/10.1159/000187357
Published Online: 12 December 2008
View article titled, Nafamostat Mesilate: A Regional Anticoagulant for Hemodialysis in Patients at High Risk for Bleeding
Open the PDF for Nafamostat Mesilate: A Regional Anticoagulant for Hemodialysis in Patients at High Risk for Bleeding in another window
Journal Articles

Effects of Recombinant Human Erythropoietin and Correction of Anemia on Platelet Function in Hemodialysis Patients

Subject Area:
Nephrology
Tadao Akizawa, Eriko Kinugasa, Tateki Kitaoka, Shozo Koshikawa
Journal: Nephron
Nephron (1991) 58 (4): 400–406.
https://doi.org/10.1159/000186470
Published Online: 11 December 2008
View article titled, Effects of Recombinant Human Erythropoietin and Correction of Anemia on Platelet Function in Hemodialysis Patients
Open the PDF for Effects of Recombinant Human Erythropoietin and Correction of Anemia on Platelet Function in Hemodialysis Patients in another window
Journal Articles

Estimation of Beta-2-Microglobulin Production from Lymphocytes in Hemodialysis Patients

Subject Area:
Nephrology
Kanji Shishido, Tadao Akizawa, Masashi Sato, Shozo Koshikawa
Journal: Nephron
Nephron (1989) 51 (1): 132–133.
https://doi.org/10.1159/000185273
Published Online: 09 December 2008
View article titled, Estimation of Beta-2-Microglobulin Production from Lymphocytes in Hemodialysis Patients
Open the PDF for Estimation of Beta-2-Microglobulin Production from Lymphocytes in Hemodialysis Patients in another window
Journal Articles

Clinical Effects of L -Threo-3,4-Dihydroxyphenylserine on Orthostatic Hypotension in Hemodialysis Patients

Subject Area:
Nephrology
Tadao Akizawa, Shozo Koshikawa, Nobutoshi Iida, Fumiaki Marumo, Takashi Akiba, Yoshindo Kawaguchi, Akio Imada, Chikao Yamazaki, Masashi Suzuki, Yoshiharu Tubakihara
Journal: Nephron
Nephron (2002) 90 (4): 384–390.
https://doi.org/10.1159/000054725
Published Online: 08 April 2002
View article titled, Clinical Effects of L -Threo-3,4-Dihydroxyphenylserine on Orthostatic Hypotension in Hemodialysis Patients
Open the PDF for Clinical Effects of L -Threo-3,4-Dihydroxyphenylserine on Orthostatic Hypotension in Hemodialysis Patients in another window